Fulgent Genetics, Inc.
FLGTUS売上高
$323M
百万USD
営業利益
$-91M
百万USD
純利益
$-61M
百万USD
ROE
-5.4%
最新FY
EPS
-
USD / 株
配当
-
USD / 株
業績推移
収益性
キャッシュフロー
財務状況
四半期業績
| 年度 | 期 | 売上高 | 純利益 | EPS |
|---|---|---|---|---|
| FY2021 | Q1 | $359M | $201M | - |
| FY2021 | Q2 | $154M | $80M | - |
| FY2021 | Q3 | $228M | $123M | - |
| FY2021 | FY | $993M | $507M | - |
| FY2022 | Q1 | $320M | $154M | - |
| FY2022 | Q2 | $125M | $12M | - |
| FY2022 | Q3 | $106M | $2M | - |
| FY2022 | FY | $619M | $143M | - |
| FY2023 | Q1 | $66M | $-15M | - |
| FY2023 | Q2 | $68M | $-11M | - |
| FY2023 | Q3 | $85M | $-13M | - |
| FY2023 | FY | $289M | $-168M | - |
| FY2024 | Q1 | $64M | $-13M | - |
| FY2024 | Q2 | $71M | $-9M | - |
| FY2024 | Q3 | $72M | $-15M | - |
| FY2024 | FY | $283M | $-43M | - |
| FY2025 | Q1 | $73M | $-12M | - |
| FY2025 | Q2 | $82M | $-19M | - |
| FY2025 | Q3 | $84M | $-7M | - |
| FY2025 | FY | $323M | $-61M | - |
| FY2026 | Q1 | $71M | $-25M | - |
財務データ
| 指標 | FY2016 | FY2017 | FY2018 | FY2019 | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| 売上高 | - | - | $21M | $33M | $422M | $993M | $619M | $289M | $283M | $323M |
| 営業利益 | $1M | $-3M | $-5M | $-0M | $290M | $676M | $179M | $-196M | $-74M | $-91M |
| 純利益 | $-5M | $-3M | $-6M | $-0M | $214M | $507M | $143M | $-168M | $-43M | $-61M |
| 総資産 | $58M | $57M | $54M | $89M | $700M | $1.3B | $1.4B | $1.2B | $1.2B | $1.2B |
| 純資産 | - | - | - | - | - | $1.2B | $1.3B | $1.1B | $1.1B | $1.1B |
| 自己資本 | $54M | $54M | $51M | $83M | $569M | $1.2B | $1.3B | $1.1B | $1.1B | $1.1B |
| 営業CF | $4M | $1M | $-1M | $6M | $141M | $539M | $254M | $27M | $21M | $-102M |
| EPS | - | - | - | - | - | - | - | - | - | - |
| BPS | $3.08 | $3.03 | $2.80 | $3.84 | $19.72 | $38.30 | $42.91 | $38.14 | $36.76 | $35.61 |
| ROE | -9.8% | -4.6% | -11.0% | -0.5% | 37.6% | 43.8% | 11.3% | -14.8% | -3.8% | -5.4% |